182 related articles for article (PubMed ID: 30838481)
1. Human DOCK2 Deficiency: Report of a Novel Mutation and Evidence for Neutrophil Dysfunction.
Moens L; Gouwy M; Bosch B; Pastukhov O; Nieto-Patlàn A; Siler U; Bucciol G; Mekahli D; Vermeulen F; Desmet L; Maebe S; Flipts H; Corveleyn A; Moshous D; Philippet P; Tangye SG; Boisson B; Casanova JL; Florkin B; Struyf S; Reichenbach J; Bustamante J; Notarangelo LD; Meyts I
J Clin Immunol; 2019 Apr; 39(3):298-308. PubMed ID: 30838481
[TBL] [Abstract][Full Text] [Related]
2. Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections.
Dobbs K; Domínguez Conde C; Zhang SY; Parolini S; Audry M; Chou J; Haapaniemi E; Keles S; Bilic I; Okada S; Massaad MJ; Rounioja S; Alwahadneh AM; Serwas NK; Capuder K; Çiftçi E; Felgentreff K; Ohsumi TK; Pedergnana V; Boisson B; Haskoloğlu Ş; Ensari A; Schuster M; Moretta A; Itan Y; Patrizi O; Rozenberg F; Lebon P; Saarela J; Knip M; Petrovski S; Goldstein DB; Parrott RE; Savas B; Schambach A; Tabellini G; Bock C; Chatila TA; Comeau AM; Geha RS; Abel L; Buckley RH; İkincioğulları A; Al-Herz W; Helminen M; Doğu F; Casanova JL; Boztuğ K; Notarangelo LD
N Engl J Med; 2015 Jun; 372(25):2409-22. PubMed ID: 26083206
[TBL] [Abstract][Full Text] [Related]
3. DOCK2 and DOCK5 act additively in neutrophils to regulate chemotaxis, superoxide production, and extracellular trap formation.
Watanabe M; Terasawa M; Miyano K; Yanagihara T; Uruno T; Sanematsu F; Nishikimi A; Côté JF; Sumimoto H; Fukui Y
J Immunol; 2014 Dec; 193(11):5660-7. PubMed ID: 25339677
[TBL] [Abstract][Full Text] [Related]
4. The Rac activator DOCK2 regulates natural killer cell-mediated cytotoxicity in mice through the lytic synapse formation.
Sakai Y; Tanaka Y; Yanagihara T; Watanabe M; Duan X; Terasawa M; Nishikimi A; Sanematsu F; Fukui Y
Blood; 2013 Jul; 122(3):386-93. PubMed ID: 23719299
[TBL] [Abstract][Full Text] [Related]
5. Multiple Immune Defects in Two Patients with Novel DOCK2 Mutations Result in Recurrent Multiple Infection Including Live Attenuated Virus Vaccine.
Li W; Sun Y; Yu L; Chen R; Gan R; Qiu L; Sun G; Chen J; Zhou L; Ding Y; Du H; Shu Z; Zhang Z; Tang X; Chen Y; Zhao X; Zhao Q; An Y
J Clin Immunol; 2023 Aug; 43(6):1193-1207. PubMed ID: 36947335
[TBL] [Abstract][Full Text] [Related]
6. Dock2 in the development of inflammation and cancer.
Chen Y; Meng F; Wang B; He L; Liu Y; Liu Z
Eur J Immunol; 2018 Jun; 48(6):915-922. PubMed ID: 29509960
[TBL] [Abstract][Full Text] [Related]
7. Dock2 generates characteristic spatiotemporal patterns of Rac activity to regulate neutrophil polarisation, migration and phagocytosis.
Machin PA; Johnsson AE; Massey EJ; Pantarelli C; Chetwynd SA; Chu JY; Okkenhaug H; Segonds-Pichon A; Walker S; Malliri A; Fukui Y; Welch HCE
Front Immunol; 2023; 14():1180886. PubMed ID: 37383235
[TBL] [Abstract][Full Text] [Related]
8. DOCK2 couples with LEF-1 to regulate B cell metabolism and memory response.
Yang L; Jing Y; Wang W; Ying W; Lin L; Chang J; Luo L; Kang D; Jiang P; Liu J; Chen Q; Miller H; Herrada AA; Kubo M; Sun J; Liu C
Biochem Biophys Res Commun; 2020 Aug; 529(2):296-302. PubMed ID: 32703426
[TBL] [Abstract][Full Text] [Related]
9. Dedicator of cytokinesis protein 2 couples with lymphoid enhancer-binding factor 1 to regulate expression of CD21 and B-cell differentiation.
Jing Y; Kang D; Liu L; Huang H; Chen A; Yang L; Jiang P; Li N; Miller H; Liu Z; Zhu X; Yang J; Wang X; Sun J; Liu Z; Liu W; Zhou X; Liu C
J Allergy Clin Immunol; 2019 Nov; 144(5):1377-1390.e4. PubMed ID: 31405607
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation complicated with EBV associated hemophagocytic lymphohistiocytosis in a patient with DOCK2 deficiency.
Aytekin ES; Çağdaş D; Tan Ç; Çavdarlı B; Bilgiç I; Tezcan İ
Turk J Pediatr; 2021; 63(6):1072-1077. PubMed ID: 35023658
[TBL] [Abstract][Full Text] [Related]
11. The role of Dock2 on macrophage migration and functions during Citrobacter rodentium infection.
Ji L; Chen Y; Xie L; Liu Z
Clin Exp Immunol; 2021 Jun; 204(3):361-372. PubMed ID: 33662140
[TBL] [Abstract][Full Text] [Related]
12. Dimerization of DOCK2 is essential for DOCK2-mediated Rac activation and lymphocyte migration.
Terasawa M; Uruno T; Mori S; Kukimoto-Niino M; Nishikimi A; Sanematsu F; Tanaka Y; Yokoyama S; Fukui Y
PLoS One; 2012; 7(9):e46277. PubMed ID: 23050005
[TBL] [Abstract][Full Text] [Related]
13. Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2.
Yasuda K; Nündel K; Watkins AA; Dhawan T; Bonegio RG; Ubellacker JM; Marshak-Rothstein A; Rifkin IR
Int Immunol; 2013 May; 25(5):295-306. PubMed ID: 23291967
[TBL] [Abstract][Full Text] [Related]
14. A novel DOCK2 variant in siblings with severe combined immunodeficiency.
Bruusgaard-Mouritsen MA; Masmas T; Borgwardt L; Nazaryan-Petersen L; Heilmann C; Madsen HO; Vibeke Marquart H
Scand J Immunol; 2023 Mar; 97(3):e13243. PubMed ID: 36541113
[No Abstract] [Full Text] [Related]
15. Essential role of Elmo1 in Dock2-dependent lymphocyte migration.
Stevenson C; de la Rosa G; Anderson CS; Murphy PS; Capece T; Kim M; Elliott MR
J Immunol; 2014 Jun; 192(12):6062-70. PubMed ID: 24821968
[TBL] [Abstract][Full Text] [Related]
16. B Cell Defects Observed in
Wong SY; Coffre M; Ramanan D; Hines MJ; Gomez LE; Peters LA; Schadt EE; Koralov SB; Cadwell K
J Immunol; 2018 Sep; 201(5):1442-1451. PubMed ID: 30012848
[TBL] [Abstract][Full Text] [Related]
17. Extra-hematopoietic immunomodulatory role of the guanine-exchange factor DOCK2.
Scharler C; Poupardin R; Ebner-Peking P; Wolf M; Schreck C; Brachtl G; Cronemberger Andrade A; Krisch L; Daheron L; Schallmoser K; Jürchott K; Küchler J; Stachelscheid H; Volk HD; Oostendorp RAJ; Strunk D
Commun Biol; 2022 Nov; 5(1):1246. PubMed ID: 36380073
[TBL] [Abstract][Full Text] [Related]
18. Sequential regulation of DOCK2 dynamics by two phospholipids during neutrophil chemotaxis.
Nishikimi A; Fukuhara H; Su W; Hongu T; Takasuga S; Mihara H; Cao Q; Sanematsu F; Kanai M; Hasegawa H; Tanaka Y; Shibasaki M; Kanaho Y; Sasaki T; Frohman MA; Fukui Y
Science; 2009 Apr; 324(5925):384-7. PubMed ID: 19325080
[TBL] [Abstract][Full Text] [Related]
19. Differential requirement for DOCK2 in migration of plasmacytoid dendritic cells versus myeloid dendritic cells.
Gotoh K; Tanaka Y; Nishikimi A; Inayoshi A; Enjoji M; Takayanagi R; Sasazuki T; Fukui Y
Blood; 2008 Mar; 111(6):2973-6. PubMed ID: 18198348
[TBL] [Abstract][Full Text] [Related]
20. DOCK2 is a Rac activator that regulates motility and polarity during neutrophil chemotaxis.
Kunisaki Y; Nishikimi A; Tanaka Y; Takii R; Noda M; Inayoshi A; Watanabe K; Sanematsu F; Sasazuki T; Sasaki T; Fukui Y
J Cell Biol; 2006 Aug; 174(5):647-52. PubMed ID: 16943182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
